377 related articles for article (PubMed ID: 16293781)
21. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Chow CC; Tsang LW; Sorensen JP; Cockram CS
Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
[TBL] [Abstract][Full Text] [Related]
22. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
23. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
[TBL] [Abstract][Full Text] [Related]
24. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
25. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Avilés-Santa L; Sinding J; Raskin P
Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
[TBL] [Abstract][Full Text] [Related]
26. Achievement of treatment goals with canagliflozin in patients with type 2 diabetes mellitus: a pooled analysis of randomized controlled trials.
Blonde L; Woo V; Mathieu C; Yee J; Vijapurkar U; Canovatchel W; Meininger G
Curr Med Res Opin; 2015 Nov; 31(11):1993-2000. PubMed ID: 26373629
[TBL] [Abstract][Full Text] [Related]
27. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
Turner R; Cull C; Holman R
Ann Intern Med; 1996 Jan; 124(1 Pt 2):136-45. PubMed ID: 8554206
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
[TBL] [Abstract][Full Text] [Related]
29. Effects of structured versus usual care on renal endpoint in type 2 diabetes: the SURE study: a randomized multicenter translational study.
Chan JC; So WY; Yeung CY; Ko GT; Lau IT; Tsang MW; Lau KP; Siu SC; Li JK; Yeung VT; Leung WY; Tong PC;
Diabetes Care; 2009 Jun; 32(6):977-82. PubMed ID: 19460913
[TBL] [Abstract][Full Text] [Related]
30. Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.
Emanuele N; Azad N; Abraira C; Henderson W; Colwell J; Levin S; Nuttall F; Comstock J; Sawin C; Silbert C; Marcovina S; Lee HS
Arch Intern Med; 1998 Dec 7-21; 158(22):2485-90. PubMed ID: 9855387
[TBL] [Abstract][Full Text] [Related]
31. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of Newly Diagnosed Type 2 Diabetes in Chinese Older Adults: A National Prospective Cohort Study.
Lv F; Cai X; Hu D; Pan C; Zhang D; Xu J; Ji L
J Diabetes Res; 2019; 2019():5631620. PubMed ID: 31828163
[TBL] [Abstract][Full Text] [Related]
33. Association of ABC (HbA1c, blood pressure and LDL-cholesterol) goal achievement with visit-to-visit ABC variability and postprandial dysmetabolism in type 2 diabetic patients.
Kitaoka K; Takenouchi A; Minato-Inokawa S; Takeuchi M; Tsuboi A; Kurata M; Fukuo K; Kazumi T
Asia Pac J Clin Nutr; 2020; 29(3):476-482. PubMed ID: 32990606
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of cardiometabolic risk reduction in patients with type 1 diabetes mellitus].
Nádas J; Putz Z; Fövényi J; Gaál Z; Gyimesi A; Hídvégi T; Hosszúfalusi N; Neuwirth G; Oroszlán T; Pánczél P; Vándorfi G; Winkler G; Wittmann I; Jermendy G
Orv Hetil; 2008 Jul; 149(27):1263-9. PubMed ID: 18579465
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of achievement of A1c, blood pressure, and cholesterol (ABC) goal in veterans with diabetes.
Vouri SM; Shaw RF; Waterbury NV; Egge JA; Alexander B
J Manag Care Pharm; 2011 May; 17(4):304-12. PubMed ID: 21534641
[TBL] [Abstract][Full Text] [Related]
36. Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial.
Newman JD; Alexander KP; Gu X; O'Brien SM; Boden WE; Govindan SC; Senior R; Moorthy N; Rezende PC; Demkow M; Lopez-Sendon JL; Bockeria O; Pandit N; Gosselin G; Stone PH; Spertus JA; Stone GW; Fleg JL; Hochman JS; Maron DJ
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006002. PubMed ID: 31718297
[TBL] [Abstract][Full Text] [Related]
37. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
Lancet; 1998 Sep; 352(9131):854-65. PubMed ID: 9742977
[TBL] [Abstract][Full Text] [Related]
38. Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F; Sonmez A; Haymana C; Sabuncu T; Dizdar OS; Gurkan E; Carlioglu AK; Agbaht K; Ozdemir D; Demirci I; Barcin C; Salman S; Tetiker T; Balci MK; Kebapci N; Ersoy C; Yumuk V; Toth PP; Satman I;
Lipids Health Dis; 2020 Nov; 19(1):237. PubMed ID: 33176832
[TBL] [Abstract][Full Text] [Related]
39. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
Nathan DM; Roussell A; Godine JE
Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
[TBL] [Abstract][Full Text] [Related]
40. Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus.
Abbasi F; Chu JW; McLaughlin T; Lamendola C; Leary ET; Reaven GM
Metabolism; 2004 Feb; 53(2):159-64. PubMed ID: 14767866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
